Home
/ CFAO
/ Competitors

CFAO Competitors and Similar CompaniesClear all

CFAO's competitors and similar companies include Lavipharm, Koye Pharmaceuticals, Menarini Group and AAA Pharmaceutical.

	CFAO CFAO is a company focused on specialized distribution in Africa and French overseas collectivities.	Lavipharm Lavipharm develops, manufactures, markets, and distributes pharmaceutical, cosmetic, and consumer health products.	Koye Pharmaceuticals Koye Pharmaceuticals manufactures and sells healthcare products.	Menarini Group Menarini Group (also known as A. Menarini Industrie Farmaceutiche Riunite) is a company that manufactures pharmaceutical products.	AAA Pharmaceutical AAA Pharmaceutical is a company manufacturing, packaging, and distributing drugs.
Founding Date	Founding Date 1887	Founding Date 1911	Founding Date 2013	Founding Date 1886	Founding Date 1986
Type	Type Private	Type Public	Type Private	Type Private	Type Private
Tags	Tags Healthcare Manufacturing & Industrial Retail consumer goods distribution pharma	Tags Healthcare Retail consumer goods cosmetics distribution drug development pharma	Tags Healthcare Manufacturing & Industrial distribution drug development pharma	Tags Healthcare Manufacturing & Industrial distribution pharma	Tags Healthcare Manufacturing & Industrial contractor distribution pharma
Locations	Locations Sèvres, FR HQ	Locations Attica, GR HQ	Locations Mumbai, IN HQ	Locations Firenze, IT HQ Tiranë, AL Yerevan, AM Chatswood, AU Chatswood, AU Wien, AT Machelen, BE see more	Locations Lumberton, US HQ Paulsboro, US
Employees	Employees 2,7041% increase	Employees 299	Employees 7071% decrease	Employees 12,3771% increase	Employees N/A
Financial
Revenue (est.)	Revenue (est.) €3.4b (FY, 2015)	Revenue (est.) €56.4m (FY, 2024)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods €2.6b (FY, 2015)	Cost of goods €26.7m (FY, 2024)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit €854.5m (FY, 2015)	Gross profit €32.3m (FY, 2024)	Gross profit N/A	Gross profit N/A	Gross profit N/A
Net income	Net income €145.6m (FY, 2015)	Net income €9m (FY, 2024)	Net income N/A	Net income N/A	Net income N/A